Concepedia

Immunotherapy in liver tumors: II. Intratumoral injection with activated tumor-infiltrating lymphocytes, intrasplenic administration of recombinant interleukin-2 and interferon α causes tumor regression and lysis

David L. Liu, Carl Håkan Håkansson, J. Seifert

Cancer Letters · 1994 · 11 citations · 12 references

DOI

Concepts

References

12

Biologic Therapy of Cancer

Robin P Reid, V. T. DeVita, S Hellman et al. · Histopathology · 1992 · 474 citations

, , +12

Biological response modifiers: the new immunotherapy.

Kenneth A. Foon · PubMed · 1989 · 201 citations

, , +14

T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.

Jeannine Alexander, S. Kudoh, Kathryn Melsop et al. · PubMed · 1993 · 155 citations

, , +16

Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma.

Andréas Mackensen, Laurent Ferradini, Guislaine Carcelain et al. · PubMed · 1993 · 122 citations

, , +17

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

Theresa L. Whiteside, E Letessier, Hirohisa Hirabayashi et al. · PubMed · 1993 · 113 citations

, , +14